A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

NCT07232719 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Retatrutide
DRUG: Placebo

Sponsor

Eli Lilly and Company